Community Navigators
Navigators
Community Participation Navigators: Testing a Peer Intervention for Adults With Serious Mental Illnesses
2 other identifiers
interventional
96
0 countries
N/A
Brief Summary
The Temple University Collaborative on Community Inclusion (TU Collaborative) is testing a community navigation intervention study based upon effective health navigation models by conducting a randomized controlled trial of the intervention to establish feasibility, efficacy, and outcomes among adults with serious mental illness (SMI).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Sep 2024
Longer than P75 for not_applicable
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 14, 2024
CompletedStudy Start
First participant enrolled
September 1, 2024
CompletedFirst Posted
Study publicly available on registry
September 19, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 1, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2032
ExpectedSeptember 19, 2024
July 1, 2024
11 months
July 14, 2024
September 10, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Temple University Community Participation Scale (TUCP):
self-reports of community participation in 22 different areas including going to a supermarket, participating in a community social group (like a book club or recreational sports team), going to a movie, or working for pay. Participants are asked to indicate the number of days in the past 30 days that they participated in each of the 22 areas, whether each participation area was important to them, and whether they felt they participated in each area enough, not enough, or too much. Recent research has found the measure to be reliable and valid. An updated version of this measure is included which adds questions related to relationships with intimate partners and children and digital participation.
baseline, and post-treatment after 6 months
WHO Disability Assessment Schedule
measures each person's capability to participate. It assesses abilities in the areas of cognition, mobility, self-care, life activities, and participation. It contains 15-items.
baseline, and post-treatment after 6 months
Secondary Outcomes (8)
Clinical Assessment Interview for Negative Symptoms
baseline, and post-treatment after 6 months
Assessment Opportunity
baseline, and post-treatment after 6 months
The Social Embeddedness Scale
baseline, and post-treatment after 6 months
Interpersonal Mattering Scale (Moschella & Baynard, 2021; Elliott et al., 2004):
baseline, and post-treatment after 6 months
3-Item UCLA Loneliness Scale (Hughes, Waite, Hawkley, & Cacioppo, 2004)
baseline, and post-treatment after 6 months
- +3 more secondary outcomes
Study Arms (2)
Community Navigator Intervention
EXPERIMENTALWeekly meetings between participant and a peer specialist. The peer specialist will help participants identify participation interests, set participation goals, and to achieve those goals while increasing confidence and competence in community participation. Initially, participants will develop a plan for community participation which includes a list of meaningful activities, identifying potential barriers and facilitators to participation. At each weekly meeting, the peer specialist will work with participants to determine what aspects of the plan are working and modify it based on any newly identified barriers, opportunities, or changes to the participants' interests or motivation. The sessions are designed to meet the participants where they are on their journey towards participating in the community. Each successive session will encourage growth and independence through peer support that is tailored to each participant's particular needs and ability.
Active control group
ACTIVE COMPARATORReceive information on community participation for adults with your health condition
Interventions
Participants receive information on how to increase their community participation
Eligibility Criteria
You may qualify if:
- meet the criteria for an SMI diagnosis of schizophrenia, schizoaffective, bipolar, or major depression diagnosis based on the MINI,
- are over the age of 18-years-old
- are fluent in English: As current intervention materials and research and intervention personnel are only fluent in English, only participants who can communicate in written and spoken English are eligible for enrollment.
- have a permanent residence without constraints on participation (free to come and go from residence without restrictions) 2
- have the ability to provide informed consent.
You may not qualify if:
- inability to provide consent (legal guardian)
- unable to speak and understand English
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, OUTCOMES ASSESSOR
- Masking Details
- Data analyst, research assistant conducting research interviews at baseline and post-treatment will be blind to participant allocation
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 14, 2024
First Posted
September 19, 2024
Study Start
September 1, 2024
Primary Completion
August 1, 2025
Study Completion (Estimated)
June 1, 2032
Last Updated
September 19, 2024
Record last verified: 2024-07
Data Sharing
- IPD Sharing
- Will share
All participants in the study will be required to complete informed consent forms which will include a clause about data preservation and sharing. Subjects will be assured that their identity will be protected and that no personally identifiable information (PII) will be disclosed as part of any data sharing. All data will be stored on Temple University's password protected, HIPAA-approved secure data server. However, because not all investigators who will need access to the data are at Temple, deidentified, anonymized data may be shared with other investigators via a secure file transfer system. All data in the study transferred between Temple University and collaborating institutions will be transferred through TUSafeSend using data encryption by way of a secure socket transfer protocol. TUSafeSend provides a secure method for transferring files containing confidential or other sensitive information, including HIPAA authorized data with PHI or PII.